Jihyun Han

Featured in: Favicon

tradingview.com Favicon

globenewswire.com Favicon

kauppalehti.fi Favicon

biospace.com Favicon

finanznachrichten.de Favicon

informazione.it

Articles

Samsung Bioepis Presents Totality-of-the-Evidence

Sep 23, 2024 | globenewswire.com | Eleni Gavriilaki |Jihyun Han |Jake Lee |Hyejin Kim

INCHEON, South Korea, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today presented the “totality-of-the-evidence” supporting extrapolation of atypical hemolytic uremic syndrome (aHUS) indication on EPYSQLI™ (SB12), a biosimilar to Soliris1 (eculizumab), at the 56th European Society for Paediatric Nephrology (ESPN 2024). The congress will be taking place from September 24 to 27, 2024 in Valencia, Spain.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →